Product Summary:
- 559 oncogenes including FDA approved and other genes in standard care and standard coverage of TMB (Tumour Mutational Burden) and MSI (Microsatellite Instability) biomarkers
- Hybridization library, 1000x coverage for solid tumours* -- Sensitive identification low-frequency mutations
- ISO/IEC 17025 / CLIA-certified clinical labs (included)
- Sample processing and DNA extraction services (included)
- *Liquid biopsy option is also available with 2000x minimum coverage (please enquire)